Cannabis Bioscience International Holdings (CBIH) Gross Margin (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Gross Margin across 5 years of filings, most recently posting 72.82% for Q1 2026.

• Gross Margin for Q1 2026 came in at 72.82%, up 10273.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 78.78% (down 801.0% YoY), and the FY2025 annual result was 86.76%, up 509.0% from the prior year.
• Gross Margin came in at 72.82% for Q1 2026 at Cannabis Bioscience International Holdings, down from 80.29% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 95.33% in Q3 2024 to a low of 29.9% in Q1 2025.
• The 5-year median for Gross Margin is 78.31% (2023), against an average of 70.71%.
• Across the five-year window, Gross Margin plunged 9747 bps in 2025 and surged 10273 bps in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Gross Margin stood at 91.41% in 2022, then decreased by 17 bps to 76.33% in 2023, then advanced by 17 bps to 89.49% in 2024, then retreated by 10 bps to 80.29% in 2025, then retreated by 9 bps to 72.82% in 2026.
• The last three Gross Margin figures came in at 72.82% (Q1 2026), 80.29% (Q4 2025), and 66.35% (Q3 2025), per Business Quant data.